TNX-833

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTNX-833
Drug Alias NameTNX-833
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTissue factor inhibitors
TargetsTissue factor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTanox Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTanox Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A